Search results
Eating two pieces of this common fruit a day slashes cholesterol levels
Daily Express· 23 hours agoIf someone has high cholesterol it means they have too much of a fatty substance known as ...
Lingering cholesterol can keep heart risk high. Marea Therapeutics has $190M to target it.
BioPharma Dive via Yahoo Finance· 1 day agoHeart disease prevention was revolutionized by the introduction of statins in the 1980s and 1990s....
Three signs of high cholesterol that can be spotted on the body without a test
Daily Express· 2 days agoBrits are being urged to look out for three potential warning signs of a silent killer condition...
Three signs you have high cholesterol that you can see without going to the GP
Daily Express· 2 days agoKeeping an eye on your cholesterol levels is a simple way to gauge whether you're eating right and...
For Your Patients: Screening and Diagnosis of High Cholesterol
MedPage Today· 6 days agoTo get a picture of how much cholesterol you have circulating in your system that could deposit on your blood vessel walls and raise the risk for a heart attack or other event ...
Signs of Alzheimer’s were everywhere. Then his brain improved
CNN via Yahoo News· 1 day agoThe weight loss and increased muscle mass lowered Nicholls’ fasting blood sugar levels, ending his...
A Complete Guide to Your Heart
Health via Yahoo News· 6 hours ago... a diet high in fruits, vegetables, whole grains, and lean proteins Engage in physical activity: Participating in at least 150 minutes of...
To Your Good Health: Statins are still beneficial, even with good cholesterol levels
The Marshall News Messenger· 2 days agoMy doctor ordered a fasting blood test, which showed that my LDL cholesterol is 119 mg/dL; my HDL is...
Three early signs of heart disease and cancer that can be spotted in your hands
Daily Express· 1 day agoHeart disease is the second leading cause of death in the UK after dementia, claiming over 60,000...
Takeda flunks pivotal epilepsy tests but mulls path to market for Ovid-partnered prospect
FierceBiotech· 2 days agoTakeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. The drug candidate, the
